Aesthetic Medical International Holdings Group Ltd: 5%+ holders

Aesthetic Medical International Holdings Group Ltd has 1 Schedule 13D or 13G filing on record since 2026-04-03. 1 holder's latest filing reports 5% or more of ordinary shares, par value us$ 0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

Swipe the table sideways to see every column.

Want the whole picture on Aesthetic Medical International Holdings Group Ltd?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Aesthetic Medical International Holdings Group Ltd: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Aesthetic Medical International Holdings Group Ltd covers

1. The Short Answer

2. Which Company This Is

3. What They Do, And How The Money Works

4. Who Runs It, And How To Reach Them

5. The Money: Funding, Valuation, Runway

6. Who Pays Them, And Who They Are Up Against

7. Warning Bells

8. Sources

   1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

Order Full ReportSee a sample report

A real finished report, first screen. Opens in a new tab.

Purpose of Transaction (Item 4)

Hainan Oriental Jiechuang Investment Partnership (Limited Partnership)

On July 20, 2022, certain parties entered into the respective agreements as below: (i) the Issuer, Dr. Zhou Pengwu, Ms. Ding Wenting (together with Dr. Zhou Pengwu, the "Founders") and Jiechuang entered into a Share Subscription Agreement (the "Jiechuang Agreement") whereby Jiechuang or its designated entity agrees to subscribe 36,402,570 newly issued ordinary shares of the Issuer for the equivalent US dollars of RMB170,000,000; (ii) the Issuer, Seefar Global Holdings Limited ("Seefar"), Jubilee Set Investments Limited ("Jubilee"), Pengai Hospital Management Corporation ("PH Management", together with Seefar and Jubilee, the "Sellers"), the Founders and Wanda entered into a Share Purchase Agreement (the "Wanda Agreement") whereby Wanda agrees to purchase 21,321,962 shares of ordinary shares of the Issuer from the Sellers for the equivalent US dollars of RMB100,000,000; (iii) the Issuer, Seefar, Jubilee, the Founders, Hawyu (HK) Limited ("Hawyu"), Wanda, Jiechuang and Peak Asia Investment Holdings V Limited ("ADV") entered into a Shareholders Agreement (the "Shareholders Agreement"). The Shareholders' Agreement governs, among other things, the appointment of the Issuer's board of directors (the "Directors") and senior management, the notice, quorum and Directors' voting arrangement of board meetings, certain lock-up commitments of the Founders and their affiliates and pre-emptive rights mechanism for the Issuer's ordinary shares. Pursuant to the Shareholders' Agreement, …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-04-03; the filing has the rest

Timeline

Swipe the table sideways to see every column.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All recent stakesThat week's stakes